Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TyVEGHA: Vi-TT Vaccine for Typhoid in Ghana
NCT04852185Phase 4Recruiting
- Sponsor
- International Vaccine Institute
- Start
- Aug 2021
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of typhoid conjugate vaccine in typhoid fever, sponsored by International Vaccine Institute. Started Aug 2021; status: recruiting.
02
Drugs
typhoid conjugate vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT04852185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04852185.